BioHiTech Global, Inc. Announces Pricing of $8.2 Million Public Offering of Common Stock
BioHiTech Global, Inc. (Nasdaq: BHTG) announced a public offering of 4,550,000 shares at $1.81 each, raising approximately $8.2 million. Maxim Group LLC leads the underwriting team, with an additional 682,500 shares available for purchase. This offering is part of an effective shelf registration statement filed with the SEC. BioHiTech specializes in sustainable waste management solutions that reduce disposal costs and carbon footprints.
- Gross proceeds of approximately $8.2 million from the public offering.
- Funds are intended to support BioHiTech's sustainable waste management operations.
- Potential dilution of shares due to the public offering.
- Market reaction to stock offerings can lead to price volatility.
CHESTNUT RIDGE, N.Y., July 27, 2020 /PRNewswire/ -- BioHiTech Global, Inc., (Nasdaq: BHTG) ("BioHiTech," or the "Company"), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a public offering price of
Maxim Group LLC is acting as the lead book-running manager for the offering and Spartan Capital Securities, LLC is acting as co-book runner for the offering.
BioHiTech Global also has granted to the underwriter a 45-day option to purchase up to an additional 682,500 shares of common stock, at the public offering price less discounts and commissions.
The public offering is being made pursuant to an effective shelf registration statement on Form S-3 that was filed with the U.S. Securities and Exchange Commission (SEC) on December 28, 2018 and declared effective on January 31, 2019. A preliminary prospectus supplement describing the terms of the public offering has been filed with the SEC. A final prospectus supplement will be filed with the SEC and will form a part of the effective registration statement. Copies of the final prospectus supplement and accompanying prospectus relating to the public offering may be obtained, when available, by contacting Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, or by telephone at (212) 895-3745.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About BioHiTech Global
BioHiTech Global, Inc. (NASDAQ: BHTG), is changing the way we think about managing waste. Our cost-effective technology solutions include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site, and proprietary real-time data analytics tools to reduce food waste generation. Our unique solutions enable businesses and municipalities of all sizes to lower disposal costs while having a positive impact on the environment. When used individually or in combination, our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage. For more information, please visit www.biohitech.com.
Forward Looking Statements
Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements, including statements about the benefits of this leasing program, potential improvements to cash flow, and the growth of its digester business, are based on many assumptions and estimates that may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the BioHiTech's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.
Company Contact:
BioHiTech Global, Inc.
Richard Galterio
Executive Vice President
Direct: 845.367.0603
rgalterio@biohitech.com
www.biohitech.com
Investors:
ir@biohitech.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/biohitech-global-inc-announces-pricing-of-8-2-million-public-offering-of-common-stock-301100148.html
SOURCE BioHiTech Global, Inc.
FAQ
What is the purpose of BioHiTech's public offering of common stock?
How much money will BioHiTech raise from the public offering?
What is the stock symbol for BioHiTech Global?
Who is managing BioHiTech's stock offering?
Is there an option for underwriters to purchase additional shares?
